Astrocytoma, Grade II Active Not Recruiting Phase 1 Trials for Varlilumab (DB11930)

IndicationStatusPhase
DBCOND0063156 (Astrocytoma, Grade II)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02924038A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)Treatment